Skip to Main Content

Author Details

David M Berman
Queen's University
1982
161
59
Prashant Mali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37199442International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer-Principles of Classification and Emerging Clinical Utility.Am J Surg Pathol2024
36255733Redirecting Polyclonal T Cells against Cancer with Soluble T-Cell Receptors.Clin Cancer Res2023
37126232Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.J Urol2023
37059267Quantitative Nuclear Grading: An Objective, Artificial Intelligence-Facilitated Foundation for Grading Noninvasive Papillary Urothelial Carcinoma.Lab Invest2023
37284047International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members.Eur Urol Open Sci2023
37037938A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients.Br J Cancer2023
36194351Prevalence of NTRK Fusions in Canadian Solid Tumour Cancer Patients.Mol Diagn Ther2023
34697907Diagnostic and prognostic implications of a three-antibody molecular subtyping algorithm for non-muscle invasive bladder cancer.J Pathol Clin Res2022
35437049Immunohistochemical Assays for Bladder Cancer Molecular Subtyping: Optimizing Parsimony and Performance of Lund Taxonomy Classifiers.J Histochem Cytochem2022
35623004Building the Canadian Bladder Cancer Research Network (CBCRN): Progress during a pandemic.Can Urol Assoc J2022
35908273Raman spectroscopy and supervised learning as a potential tool to identify high-dose-rate-brachytherapy induced biochemical profiles of prostate cancer.J Biophotonics2022
33771477International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma.Eur Urol Focus2022
35073341Mutually exclusive mutation profiles define functionally related genes in muscle invasive bladder cancer.PLoS One2022
35196610Transient high-grade second-degree atrioventricular block secondary to transvenous atrial septal defect occlusion in a dog.J Vet Cardiol2022
32884130High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohorts.Mod Pathol2021
34120811Lack of definitive presurgical pathological diagnosis is associated with inadequate surgical margins in breast-conserving surgery.Eur J Surg Oncol2021
34337534Sexual Dimorphism in Outcomes of Non-muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint.Eur Urol Open Sci2021
34337530Analysis of Prostate Cancer Tumor Microenvironment Identifies Reduced Stromal CD4 Effector T-cell Infiltration in Tumors with Pelvic Nodal Metastasis.Eur Urol Open Sci2021
32195773The Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid Following Intravenous Administration: A Report of Successfully Treated Infant with Mycoplasma hominis Meningitis.Pediatr Infect Dis J2020
34337469Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis.Eur Urol Open Sci2020
31708295Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up.Eur Urol2020
31880965Value of Biomarker Expression for Randomized Clinical Trial Design: One (More) Missed Opportunity.J Clin Oncol2020
33164241Use of cidofovir with extracorporeal membrane oxygenation to treat adenovirus-associated acute respiratory distress syndrome in paediatric patients- a case series.J Clin Pharm Ther2020
33275556Building a Canadian Translational Bladder Cancer Research Network.Can Urol Assoc J2020
32763409Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification-Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples.J Mol Diagn2020
32506642Development and initial clinical correlation of a DNA methylation-based blood test for prostate cancer.Prostate2020
32209217Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection.Can Urol Assoc J2020
32129857Risk Stratification of Prostate Cancer Through Quantitative Assessment of PTEN Loss (qPTEN).J Natl Cancer Inst2020
30604486Molecular profiling in muscle-invasive bladder cancer: more than the sum of its parts.J Pathol2019
31692121Resource utilization of cytomegalovirus immune globulin in prevention and treatment of cytomegalovirus infection in pediatric heart transplantation.Clin Transplant2019
30017404Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective Trial.Eur Urol2019
31503357Functional validation of metabolic genes that distinguish Gleason 3 from Gleason 4 prostate cancer foci.Prostate2019
31530281Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling.Cell Commun Signal2019
30889379The Proteogenomic Landscape of Curable Prostate Cancer.Cancer Cell2019
31160688Reliable identification of prostate cancer using mass spectrometry metabolomic imaging in needle core biopsies.Lab Invest2019
29460925Clinical implications of PTEN loss in prostate cancer.Nat Rev Urol2018
31329806Erratum: Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer.Bladder Cancer2018
27870104Clinical Experience with Daptomycin in Pediatrics.Pharmacotherapy2017
29152550Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer.Bladder Cancer2017
28640876Reliability and performance of commercial RNA and DNA extraction kits for FFPE tissue cores.PLoS One2017
26861919In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading.Virchows Arch2016
26569091The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation.Bone Marrow Transplant2016
26407259Failure to Validate a Multivariable Clinical Prediction Model to Identify Pediatric Intensive Care Unit Patients at High Risk for Candidemia.J Pediatric Infect Dis Soc2016
26446945Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer.Clin Cancer Res2016
27583817Preparation of Formalin-fixed Paraffin-embedded Tissue Cores for both RNA and DNA Extraction.J Vis Exp2016
27152194Molecular characterization of Gleason patterns 3 and 4 prostate cancer using reverse Warburg effect-associated genes.Cancer Metab2016
25168574Pathological factors associated with survival benefit from adjuvant chemotherapy (ACT): a population-based study of bladder cancer.BJU Int2015
26599435Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma.PLoS One2015
26232466Surveys and Response Rates.Pediatr Rev2015
26205340Evolving synergistic combinations of targeted immunotherapies to combat cancer.Nat Rev Cancer2015
  • 1 - 50 of 161

Recommended Authors

Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 12
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 18
Jonathan Chou
University of California san francisco
Career Start Year 2005
Number of shared co-authors 8
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 24
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 24
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 16
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 7
Mark E Smolkin
University of Virginia
Career Start Year 2002
Number of shared co-authors 1
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 3
Christopher J Howlett
Western University
Career Start Year 1999
Number of shared co-authors 3
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 6
Franklin W Huang
Institute for Human Genetics, University of California san francisco
Career Start Year 1998
Number of shared co-authors 15
Robert Kim
University of California
Career Start Year 1996
Number of shared co-authors 4
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 28
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 4
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 12
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 1
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 1
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 9
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 15
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 14
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 19
Beatrice S Knudsen
University of Utah
Career Start Year 1986
Number of shared co-authors 19
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 5
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 2
Michael J Becich
University of Pittsburgh School of Medicine
Career Start Year 1982
Number of shared co-authors 2
Lawrence D True
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 31
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 17
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 12
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 4

Collaborators

David Robert Siemens
Queen's University
Co-authored papers 19
Luigi Marchionni
Weill-Cornell School of Medicine
Co-authored papers 11
Brian W Simons
Center for Comparative Medicine, Baylor College of Medicine
Co-authored papers 10
Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 10
Tamara Jamaspishvili
Queen's University
Co-authored papers 9
Ashley E Ross
Northwestern University
Co-authored papers 8
Palak G Patel
Queen's University
Co-authored papers 8
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 7
Alfred G Gilman
Co-authored papers 6
John M S Bartlett
University of Edinburgh
Co-authored papers 6
Massimo Loda
Weill Medical College of Cornell University
Co-authored papers 6
David N Watkins
Research Institute in Oncology and Hematology
Co-authored papers 6
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 5
David W Russell
Co-authored papers 5
Karl-Philippe Gu??rard
McGill University and the Research Institute of the McGill University Health Centre
Co-authored papers 5
Tamara L Lotan
Johns Hopkins University School of Medicine
Co-authored papers 5
Jeremy A Squire
University of Sao Paulo
Co-authored papers 5
William Matsui
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Co-authored papers 5
Wayne Yu
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Co-authored papers 5
Toni K Choueiri
Dana-Farber Cancer Institute
Co-authored papers 4
Stephen B Baylin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Co-authored papers 4
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Madeleine Moussa
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 3
Leslie Cope
Johns Hopkins University School of Medicine
Co-authored papers 3
Lance A Liotta
Co-authored papers 3
Markus Riester
Novartis Institutes for BioMedical Research
Co-authored papers 3
David L Rimm
Yale University School of Medicine
Co-authored papers 3
Fadi Brimo
McGill University Health Centre, McGill University
Co-authored papers 3
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Co-authored papers 3
Walead Ebrahimizadeh
Current affiliation: IMV Inc.
Co-authored papers 3
Release 1.2